| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC0614 |
| Trial ID | JPRN-jRCT1080224971 |
| Disease | Acute Lymphoblastic Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | UCAR-T19 |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | Dose Escalation Study of UCART19 in Adult Patients With Relapsed / Refractory B-cell Acute Lymphoblastic Leukaemia |
| Year | 2019 |
| Country | North America|Japan |
| Company sponsor | Nihon Servier |
| Other ID(s) | NCT02746952 |
| Cohort 1 | |||||||||||||||
|
|||||||||||||||